• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
NC Harm Reduction Coalition

NC Harm Reduction Coalition

Dedicated to the implementation of harm reduction interventions, public health strategies, drug policy transformation, and justice reform in North Carolina and throughout the American South.

  • About
    • What is Harm Reduction?
    • Staff
      • Board of Directors
    • Contact
      • Media Linkage
        • Media Mentions
          • 2016
          • 2015
          • 2014
          • 2013
          • 2012
          • 2011
          • 2010
    • Allies
      • NC MAT Naloxone Access Partnerships
    • Work at NCHRC
      • Fair Employment
    • Gallery
  • Programs and Services
    • Syringe Services Programs
      • NCHRC Syringe Access Stance:
      • Syringe Law in NC
      • Naloxone 101
        • Getting Naloxone From NCHRC
        • 911 Good Samaritan and Naloxone Law in NC
    • Overdose Prevention
      • Overdose Prevention Laws in NC
      • Speed Overdose (Overamping)
      • Overdose Prevention Fact Sheets
    • Post Overdose Response and Law Enforcement
      • Georgia Overdose Prevention
      • Georgia OD Prevention and Naloxone Brochure
    • LEAD
      • Law Enforcement Tools and Resources
        • Law Enforcement Voices and Testimony
        • Preventing Occupational Fentanyl and Fentanyl Analog Exposure to Emergency Responders
        • Law Enforcement FAQ on Naloxone and Syringe Exchange
      • LEAD Policies and MOUs
      • US Law Enforcement Who Carry Naloxone
      • Law Enforcement Training Booking and Events
  • Resources
    • Safer Injection Drug Use
    • Safer Sex Work
    • Safer Crack Use
    • Harm Reduction & Trans Health
    • Research
    • Videos
    • Testimonials
  • Advocacy
    • Take Action and Get Involved
      • Inadequate Treatment
    • Legislative Victories
    • Press Releases
    • News and Events
      • News
      • Events
  • Shop NCHRC
    • Donate
  • In Memory of
  • Show Search
Hide Search

FAQ ON SYRINGE EXCHANGE PROGRAMS

What are Syringe Exchange Programs (SEPs)?

SEPs collect used and potentially contaminated syringes from people who inject drugs and exchange them for sterile syringes in order to prevent HIV, hepatitis C, and needle-stick injury. Most SEPs also offer a variety of social services, including access to housing progams, career services and addiction treatment.

Why does North Carolina need SEPs?

North Carolina is experiencing a rapid rise in injection drug use, leading to increases in hepatitis C infections. Over the past four years acute hepatitis C cases have more than doubled[1], and the cost of treating North Carolina Medicaid patients with chronic hepatitis C rose from around 8 million dollars in 2013 to over 50 million in 2014[2]. These costs will continue to rise, creating an additional burden on NC taxpayers unless we act now. Also, heroin death rates have tripled over the past four years[3] and programs are needed to help people who struggle with addiction to seek treatment.

Do SEPs encourage drug use?

NO. Decades of scientific evidence have concluded that SEPs DO NOT cause any increase in drug use[4]. In fact, many studies have demonstrated that SEPs decrease drug use by effectively connecting people who use drugs to treatment.

Do people who use drugs actually return syringes to SEPs?

YES. Research indicates that over 90% of syringes distributed by SEPs are returned[5].

How do SEPs connect people to drug treatment?

People who use drugs are often marginalized and encounter numerous barriers when seeking drug treatment. SEPs act as a gateway to treatment by helping SEP clients connect to resources and navigate the complex application process. In fact, research indicates that SEP participants are five times more likely to enter drug treatment than non-participants[6].

How do SEPs benefit law enforcement?

It is also estimated that one in three officers will be stuck by a syringe during their career and 28% will suffer more than one needle-stick injury[7]. SEPs are proven to lower needle-stick injury to law enforcement by 66%[8].

How do SEPs decrease HIV, hepatitis C and hepatitis B among injection drug users?

SEPs decrease the transmission of bloodborne disease by decreasing the likelihood that people who inject drugs will share syringes and by collecting used syringes from the community and properly disposing of them. Studies show that SEPs decrease hepatitis C transmission among people who inject drugs by as much as 50%[9]. HIV infection rates have decreased by as much as 80% in areas with SEPs[10].

How do SEPs save taxpayer money?

The lifetime cost of treating an HIV-positive person is estimated to be between $385,200 and $618,900[11], while hepatitis C costs $100,000-$500,000 to treat[12]. Since most people who inject drugs are uninsured or reliant on programs such as Medicaid, taxpayers bear most of this cost. With individual needles and syringes costing less than 50 cents, it is far cheaper to prevent a new case of HIV than to assume many years of treatment costs. According to a recent analysis, every dollar spent on SEPs would save at least an estimated three dollars in treatment costs averted[13].

How do SEPs decrease crime?

SEPs decrease crime by connecting participants to drug treatment, housing, food pantries and other social services. In one study, Baltimore neighborhoods with syringe exchange programs experienced an 11% decrease in crime compared to those without syringe exchange, which saw an 8% increase in criminal activity[14].

How many states have SEPs?

Twenty states in the U.S. explicitly authorize SEPs, including Kentucky, Indiana and Nebraska. Georgia and West Virginia also have SEPs in some major cities.


[1] NC Department of Health and Human Services surveillance data

[2] NC Department of Health and Human Services surveillance data

[3] NC Injury Prevention Branch.

[4] Institute of Medicine. Preventing HIV Infection Among Injecting Drug Users in High-Risk Countries. An Assessment of the Evidence. Washington, D.C.: National Academies Press; 2006.

[5] Ksobiech, K, 2004, Harm Reduction Journal. Return Rates for Needle Exchange Programs: A common criticism answered. http://www.harmreductionjournal.com/content/1/1/2

[6] Hagan H, McGough JP, Thiede H, Hopkins S, Duchin J, Alexander ER., “Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors,” Journal of Substance Abuse Treatment, vol. 19, 2000, p. 247–252.

[7] Lorenz, J., Hill,. J & Samini, B. (2000). Occupational Needle-stick Injury in a Metropolitan Police Force. American Journal of Preventative Medicine, 18, 146-150.

[8] Groseclose, S.L. et al., “Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers—Connecticut, 1992-1993,” Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, vol. 10. no. 1, 1995, p. 82–89.

[9] Turner, K. et al. “The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence,” Addiction, E-publication ahead of print, 2011.

[10] Des Jarlais, D.C., Arasteh, K., & Friedman, S. R. (2011). HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years. Substance Use & Misuse, 46(2-3), 131-139.

[11] Schackman, B.R., Gebo, K.A., & Walensky, R.P. et al. (November 2006). The lifetime cost of current Human Immunodeficiency Virus care in the United States. Medical Care, 44(11), 990-997.

[12] Mizuno, Y. et al. (2006). Correlates of health care utilization among HIV-seropositive injection drug users. AIDS Care,18(5):417-25.

[13] Nguyen, T.Q., Weir, B.W., Pinkerton, S.D., Des Jarlais, D.C., & Holtgrave, D. (July 23, 2012). Increasing investment in syringe exchange is cost-saving HIV prevention: modeling hypothetical syringe coverage levels in the United States (MOAE0204). Presented at the XIX International AIDS Conference, Washington D.C. Session available online at http://pag.aids2012.org/session.aspx?s=198. (date last accessed: December 11, 2012)

[14] Center for Innovative Public Policies. Needle Exchange Programs: Is Baltimore a Bust? Tamarac, Fl.: CIPP; April 2001.

Primary Sidebar

Related

  • Syringe Access Laws in NC
  • Fact Sheets on Syringe Exchange

Sign up for the NCHRC Newsletter

Sign up to receive email updates and to stay up-to-date with event and program information.
  • This field is for validation purposes and should be left unchanged.
Donate Now

Testimonials

“The help I got from the harm reduction program was more than just clean equipment, it was about being with people who didn’t judge me for my addiction, and who really wanted to help.”
~ Sam, a 50-year-old former drug user and sex worker in Carrboro, NC

“Too often, drug users suffer discrimination, are forced to accept treatment, marginalized, and often harmed by approaches which over-emphasize criminalization and punishment while under-emphasizing harm reduction and respect for human rights. This is despite the longstanding evidence that a harm reduction approach is the most effective way of protecting rights, limiting personal suffering, and reducing the incidence of HIV.”
~ Navanethem Pillay, UN High Commissioner for Human Rights, March 10, 2009

Discover more

Get Help Resources Programs

Footer

NC Harm Reduction Coalition

4024 Barrett Dr.
Suite 101
Raleigh, NC 27609
Email: Executive.Director@nchrc.org

Copyright © 2023 · All Rights Reserved · Website by Tomatillo Design

Connect with Us

  • Facebook
  • LinkedIn
  • Twitter
  • Vimeo